AR045234A1 - Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. - Google Patents
Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen.Info
- Publication number
- AR045234A1 AR045234A1 ARP040102850A ARP040102850A AR045234A1 AR 045234 A1 AR045234 A1 AR 045234A1 AR P040102850 A ARP040102850 A AR P040102850A AR P040102850 A ARP040102850 A AR P040102850A AR 045234 A1 AR045234 A1 AR 045234A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxialquil
- almidon
- pharmaceutical compositions
- compositions containing
- produce derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/10—Alkyl or cycloalkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/003—Crosslinking of starch
- C08B31/006—Crosslinking of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
- C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente se refiere a un método para producir un derivado de almidón de hidroxialquilo que comprende la reacción del almidón de hidroxialquilo de la fórmula (1), en su extremo reductor el cual no es oxidado antes de dicha reacción, con un compuesto de fórmula (2): R'-NH-R'', en la cual R1, R2, y R3 son independientemente hidrógeno o un grupo hidroxialquilo lineal o ramificado, y en el cual ya sea R' o R'' o R' y R'' comprenden por lo menos un grupo funcional X capaz de ser sometido a reacción con por lo menos otro compuesto antes o después de la reacción de (1) y (2), al igual que el derivado de almidón de hidroxialquilo como tal, que se puede obtener por medio de dicho método, y a una composición farmacéutica que comprende dicho derivado de almidón de hidroxialquilo.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40978102P | 2002-09-11 | 2002-09-11 | |
EP02020425A EP1400533A1 (en) | 2002-09-11 | 2002-09-11 | HASylated polypeptides, especially HASylated erythropoietin |
PCT/EP2003/008858 WO2004024761A1 (en) | 2002-09-11 | 2003-08-08 | Hasylated polypeptides, especially hasylated erythropoietin |
PCT/EP2003/008859 WO2004024777A1 (en) | 2002-09-11 | 2003-08-08 | Hydroxyalkyl starch derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045234A1 true AR045234A1 (es) | 2005-10-19 |
Family
ID=31995520
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030103141A AR041097A1 (es) | 2002-09-11 | 2003-08-29 | Derivados de polipeptidos con hidroxilalquilalmidon especialmente derivados de eritropoyetina con hidroxilalquilalmidon |
ARP040102851A AR045235A1 (es) | 2002-09-11 | 2004-08-09 | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. |
ARP040102850A AR045234A1 (es) | 2002-09-11 | 2004-08-09 | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030103141A AR041097A1 (es) | 2002-09-11 | 2003-08-29 | Derivados de polipeptidos con hidroxilalquilalmidon especialmente derivados de eritropoyetina con hidroxilalquilalmidon |
ARP040102851A AR045235A1 (es) | 2002-09-11 | 2004-08-09 | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. |
Country Status (25)
Country | Link |
---|---|
US (5) | US8618266B2 (es) |
EP (8) | EP2143736B1 (es) |
JP (4) | JP2006516534A (es) |
KR (3) | KR101045401B1 (es) |
CN (2) | CN1681844A (es) |
AR (3) | AR041097A1 (es) |
AT (3) | ATE406387T1 (es) |
AU (6) | AU2003253399B2 (es) |
BR (3) | BR0314107A (es) |
CA (2) | CA2496317C (es) |
CY (1) | CY1109813T1 (es) |
DE (7) | DE60323192D1 (es) |
DK (3) | DK1398327T3 (es) |
ES (4) | ES2213507T3 (es) |
HK (4) | HK1063477A1 (es) |
IL (5) | IL166506A0 (es) |
MX (4) | MXPA05002591A (es) |
NO (2) | NO20051427L (es) |
PL (3) | PL375037A1 (es) |
PT (3) | PT1398322E (es) |
RU (3) | RU2329274C2 (es) |
SI (2) | SI1398328T1 (es) |
TW (1) | TW200418875A (es) |
WO (3) | WO2004024776A1 (es) |
ZA (1) | ZA200600651B (es) |
Families Citing this family (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10112825A1 (de) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
EP1400533A1 (en) * | 2002-09-11 | 2004-03-24 | Fresenius Kabi Deutschland GmbH | HASylated polypeptides, especially HASylated erythropoietin |
DE10242076A1 (de) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | HAS-Allergen-Konjugate |
KR101045401B1 (ko) | 2002-09-11 | 2011-06-30 | 프레제니우스 카비 도이치란트 게엠베하 | 하이드록시알킬 전분 유도체 |
EP1549350B1 (en) | 2002-10-08 | 2008-09-24 | Fresenius Kabi Deutschland GmbH | Pharmaceutically active oligosaccharide conjugates |
DE10256558A1 (de) * | 2002-12-04 | 2004-09-16 | Supramol Parenteral Colloids Gmbh | Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe |
BRPI0412671A (pt) * | 2003-08-08 | 2006-10-03 | Fresenius Kabi De Gmbh | conjugados de um polìmero e uma proteìna ligados por um grupo de ligação de oxima |
SG145746A1 (en) * | 2003-08-08 | 2008-09-29 | Fresenius Kabi De Gmbh | Conjugates of hydroxyalkyl starch and g-csf |
WO2005014655A2 (en) * | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
AU2004262921B2 (en) * | 2003-08-08 | 2010-05-13 | Octapharma Ag | Conjugates of hydroxyalkyl starch and G-CSF |
US8754031B2 (en) | 2004-03-08 | 2014-06-17 | Oncolix, Inc. | Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway |
BRPI0508607A (pt) * | 2004-03-11 | 2007-07-31 | Fresenius Kabi De Gmbh | conjugados de amido de hidroxialquila e uma proteìna, preparados pela aminação redutiva |
EP1732609B1 (en) * | 2004-03-11 | 2012-07-11 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and a protein |
TW200603818A (en) * | 2004-03-11 | 2006-02-01 | Fresenius Kabi De Gmbh | Conjugates of hydroxyethyl starch and erythropoietin |
US7589063B2 (en) | 2004-12-14 | 2009-09-15 | Aplagen Gmbh | Molecules which promote hematopoiesis |
AU2006222187A1 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch |
WO2006094826A2 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Method for coupling enzymatically activated glycoconjugates to a hydroxyalkyl starch |
EP1762250A1 (en) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
EP3669894A3 (en) | 2006-06-30 | 2020-08-26 | Syntab Therapeutics GmbH | Novel multifunctional compounds for pharmaceutical purposes |
WO2008012540A1 (en) * | 2006-07-25 | 2008-01-31 | Lipoxen Technologies Limited | N-terminal polysialylation |
EP2120998B1 (en) | 2006-11-28 | 2013-08-07 | HanAll Biopharma Co., Ltd. | Modified erythropoietin polypeptides and uses thereof for treatment |
CN105838699A (zh) * | 2006-12-15 | 2016-08-10 | 巴克斯艾尔塔公司 | 具有延长的体内半衰期的因子VIIa-聚唾液酸结合物 |
NO2457920T3 (es) | 2007-01-18 | 2018-03-24 | ||
CN101485897B (zh) | 2008-01-14 | 2015-05-20 | 纪欣 | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 |
ES2750254T3 (es) | 2007-09-27 | 2020-03-25 | Amgen Inc | Formulaciones farmacéuticas |
WO2009064838A1 (en) | 2007-11-15 | 2009-05-22 | Amgen, Inc. | Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration |
EP2070950A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
EP2070951A1 (en) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Method for producing a hydroxyalkyl starch derivatives with two linkers |
EP2803675A3 (en) | 2008-01-25 | 2014-12-24 | Amgen, Inc | Ferroportin antibodies and methods of use |
CA2722425A1 (en) * | 2008-04-28 | 2009-11-05 | Surmodics, Inc. | Poly-.alpha.(1-4)glucopyranose-based matrices with hydrazide crosslinking |
US9315577B2 (en) | 2008-05-01 | 2016-04-19 | Amgen Inc. | Anti-hepcidin antibodies and methods of use |
EP2166085A1 (en) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalent modified cells |
PE20110426A1 (es) | 2008-07-23 | 2011-07-01 | Ambrx Inc | Polipeptidos g-csf bovinos modificados |
US8680263B2 (en) * | 2008-09-19 | 2014-03-25 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
WO2010056981A2 (en) | 2008-11-13 | 2010-05-20 | Massachusetts General Hospital | Methods and compositions for regulating iron homeostasis by modulation bmp-6 |
US9011920B2 (en) | 2008-12-06 | 2015-04-21 | B. Braun Melsungen Ag | Transport-mediating colloidal pharmaceutical compounds |
US8648046B2 (en) | 2009-02-26 | 2014-02-11 | Oncolix, Inc. | Compositions and methods for visualizing and eliminating cancer stem cells |
KR101672401B1 (ko) | 2009-02-26 | 2016-11-16 | 온코릭스, 아이엔씨. | 암 줄기 세포를 가시화하고 제거하기 위한 조성물 및 방법 |
RU2549492C2 (ru) * | 2009-03-31 | 2015-04-27 | Б. Браун Мельзунген Аг | Продукты слияния аминированных полисахаридов |
EP2459224B1 (en) | 2009-07-27 | 2016-06-01 | Baxalta GmbH | Blood coagulation protein conjugates |
US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
KR101912335B1 (ko) * | 2009-07-27 | 2018-10-26 | 리폭센 테크놀로지즈 리미티드 | 비혈액 응고 단백질의 글리코폴리시알화 |
US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
RU2744370C2 (ru) * | 2009-07-27 | 2021-03-05 | Баксалта Инкорпорейтед | Конъюгаты белков свертывания крови |
EP2490957B1 (en) | 2009-10-23 | 2016-11-23 | Amgen, Inc | Vial adapter and system |
PE20121799A1 (es) | 2009-12-21 | 2013-01-02 | Ambrx Inc | Polipeptidos de somatotropina porcina modificados y sus usos |
NZ600361A (en) | 2009-12-21 | 2014-06-27 | Ambrx Inc | Modified bovine somatotropin polypeptides and their uses |
WO2011098095A1 (en) | 2010-02-09 | 2011-08-18 | Aplagen Gmbh | Peptides binding the tpo receptor |
HUE026173T2 (en) | 2010-06-07 | 2016-05-30 | Amgen Inc | pharmaceutical Pump |
EP2591009A1 (en) | 2010-07-09 | 2013-05-15 | Fresenius Kabi Deutschland GmbH | Nitric oxide delivering hydroxyalkyl starch derivatives |
US20130178437A1 (en) * | 2010-07-09 | 2013-07-11 | Fresenius Kabi Deutschland Gmbh | Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
US20130217871A1 (en) * | 2010-07-09 | 2013-08-22 | Helmut Knoller | Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
WO2012004005A1 (en) * | 2010-07-09 | 2012-01-12 | Fresenius Kabi Deutschland Gmbh | Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
LT2598172T (lt) | 2010-07-30 | 2019-08-26 | Baxalta GmbH | Nukleofiliniai katalizatoriai, skirti oksiminei jungčiai sudaryti |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
CN103269723B (zh) | 2010-12-22 | 2017-04-05 | 百深有限责任公司 | 用于偶联水溶性脂肪酸衍生物与蛋白质的材料和方法 |
AU2012236573B2 (en) | 2011-03-31 | 2016-06-02 | Amgen Inc. | Vial adapter and system |
DK2699293T3 (en) | 2011-04-20 | 2019-04-29 | Amgen Inc | AUTO INJECTION DEVICE |
WO2012166622A1 (en) | 2011-05-27 | 2012-12-06 | Baxter International Inc. | Therapeutic proteins with increased half-life and methods of preparing same |
US20150044714A1 (en) * | 2011-06-07 | 2015-02-12 | Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine | sPLA2 MONITORING STRIP |
WO2013021056A1 (en) | 2011-08-10 | 2013-02-14 | Ludwig-Maximilians-Universität München | Method for the controlled intracellular delivery of nucleic acids |
MX357209B (es) | 2011-10-14 | 2018-06-29 | Amgen Inc | Inyector y metodo de ensamble. |
WO2013113503A1 (en) | 2012-01-31 | 2013-08-08 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and an oligonucleotide |
AU2013204754C1 (en) | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
ES2780395T3 (es) | 2012-11-21 | 2020-08-25 | Amgen Inc | Dispositivo de administración de fármacos |
WO2014084110A1 (ja) * | 2012-11-30 | 2014-06-05 | 株式会社糖鎖工学研究所 | 糖鎖付加リンカー、糖鎖付加リンカーと生理活性物質とを含む化合物またはその塩、及びそれらの製造方法 |
EP2968775B1 (en) | 2013-03-15 | 2019-12-18 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
MX359794B (es) | 2013-03-15 | 2018-10-10 | Intrinsic Lifesciences Llc | Anticuerpos anti-hepcidina y usos de los mismos. |
ES2973257T3 (es) | 2013-03-15 | 2024-06-19 | Amgen Inc | Casete de fármaco, autoinyector y sistema de autoinyector |
CA2907471A1 (en) * | 2013-03-20 | 2014-09-25 | Fresenius Kabi Deutschland Gmbh | Hydroxyalkyl starch derivatives as reactants for coupling to thiol groups |
EP2976366A1 (en) * | 2013-03-20 | 2016-01-27 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives as reactants for coupling to thiol groups |
WO2014147174A1 (en) * | 2013-03-20 | 2014-09-25 | Fresenius Kabi Deutschland Gmbh | Process for the preparation of thiol functionalized hydroxyalkyl starch derivatives |
LT2976117T (lt) | 2013-03-22 | 2021-02-25 | Amgen Inc. | Purkštuvas ir surinkimo būdas |
JP6520712B2 (ja) | 2013-09-24 | 2019-05-29 | 味の素株式会社 | 糖アミノ酸およびその用途 |
CN105873626A (zh) | 2013-10-24 | 2016-08-17 | 美国安进公司 | 注射器和组装方法 |
US10758683B2 (en) | 2013-10-24 | 2020-09-01 | Amgen Inc. | Drug delivery system with temperature-sensitive control |
US10994112B2 (en) | 2014-02-05 | 2021-05-04 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
CN105960277A (zh) * | 2014-02-10 | 2016-09-21 | 霍尼韦尔国际公司 | 用于液相氟化的反应器设计 |
WO2015132724A1 (en) | 2014-03-05 | 2015-09-11 | Pfizer Inc. | Improved muteins of clotting factor viii |
US10722655B2 (en) | 2014-05-07 | 2020-07-28 | Amgen Inc. | Autoinjector with shock reducing elements |
JP6822843B2 (ja) | 2014-06-03 | 2021-01-27 | アムジエン・インコーポレーテツド | 薬物送達装置によって収集されたデータを遠隔で処理するためのシステム及び方法 |
CN104072608A (zh) * | 2014-06-23 | 2014-10-01 | 山东齐都药业有限公司 | 含羧基羟乙基淀粉衍生物修饰的牛血清白蛋白偶联物及其制备方法 |
WO2016049036A1 (en) | 2014-09-22 | 2016-03-31 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
EP3943135A3 (en) | 2014-10-14 | 2022-06-29 | Amgen Inc. | Drug injection device with visual and audible indicators |
EP3689394A1 (en) | 2014-12-19 | 2020-08-05 | Amgen Inc. | Drug delivery device with live button or user interface field |
US10799630B2 (en) | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
CA2976935C (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
EP3261690B1 (en) | 2015-02-27 | 2021-12-15 | Amgen Inc. | Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
JP7082568B2 (ja) | 2015-12-09 | 2022-06-08 | アムジエン・インコーポレーテツド | 信号伝達キャップ付き自動注射器 |
US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
EP3721922B1 (en) | 2016-03-15 | 2022-05-04 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
WO2017189089A1 (en) | 2016-04-29 | 2017-11-02 | Amgen Inc. | Drug delivery device with messaging label |
US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
AU2017263558B2 (en) | 2016-05-13 | 2022-12-22 | Amgen Inc. | Vial sleeve assembly |
EP3458988B1 (en) | 2016-05-16 | 2023-10-18 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
CN109152817A (zh) | 2016-05-20 | 2019-01-04 | 瑞士奥克特珐玛公司 | 具有改进的药代动力学的糖基化vwf融合蛋白 |
GB201609083D0 (en) | 2016-05-24 | 2016-07-06 | Syntab Therapeutics Gmbh | Synthetic compound |
US11541176B2 (en) | 2016-06-03 | 2023-01-03 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
US20190328965A1 (en) | 2016-08-17 | 2019-10-31 | Amgen Inc. | Drug delivery device with placement detection |
WO2018081234A1 (en) | 2016-10-25 | 2018-05-03 | Amgen Inc. | On-body injector |
WO2018136398A1 (en) | 2017-01-17 | 2018-07-26 | Amgen Inc. | Injection devices and related methods of use and assembly |
US11752258B2 (en) | 2017-02-17 | 2023-09-12 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
AU2018221351B2 (en) | 2017-02-17 | 2023-02-23 | Amgen Inc. | Insertion mechanism for drug delivery device |
JP2020508803A (ja) | 2017-03-06 | 2020-03-26 | アムジエン・インコーポレーテツド | 作動防止特徴部を備える薬物送達デバイス |
SG11201908058UA (en) | 2017-03-07 | 2019-09-27 | Amgen Inc | Needle insertion by overpressure |
EP3592404A1 (en) | 2017-03-09 | 2020-01-15 | Amgen Inc. | Insertion mechanism for drug delivery device |
WO2018172219A1 (en) | 2017-03-20 | 2018-09-27 | F. Hoffmann-La Roche Ag | Method for in vitro glycoengineering of an erythropoiesis stimulating protein |
FI3600491T3 (fi) | 2017-03-28 | 2023-10-20 | Amgen Inc | Männänvarren ja ruiskukokoonpanon järjestelmä ja menetelmä |
JP7200134B2 (ja) | 2017-06-08 | 2023-01-06 | アムジエン・インコーポレーテツド | トルク駆動式薬物送達デバイス |
AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
EP3641857A1 (en) | 2017-06-22 | 2020-04-29 | Amgen Inc. | Device activation impact/shock reduction |
MA49461A (fr) | 2017-06-23 | 2020-04-29 | Amgen Inc | Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur |
ES2972207T3 (es) | 2017-07-14 | 2024-06-11 | Amgen Inc | Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble |
EP4292576A3 (en) | 2017-07-21 | 2024-01-17 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
MA49676A (fr) | 2017-07-25 | 2020-06-03 | Amgen Inc | Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé |
EP3658203B1 (en) | 2017-07-25 | 2022-08-31 | Amgen Inc. | Drug delivery device with gear module and related method of assembly |
MA49838A (fr) | 2017-08-09 | 2020-06-17 | Amgen Inc | Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre |
EP3668567A1 (en) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Wearable injector with sterile adhesive patch |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
MA50611A (fr) | 2017-10-04 | 2020-08-12 | Amgen Inc | Adaptateur d'écoulement destiné à un dispositif d'administration de médicament |
CN111132711B (zh) | 2017-10-06 | 2022-07-01 | 安进公司 | 带有联锁组件的药物递送装置及相关组装方法 |
IL273323B1 (en) | 2017-10-09 | 2024-06-01 | Amgen Inc | Drug delivery device with drive assembly and related assembly method |
US11826480B2 (en) | 2017-11-03 | 2023-11-28 | Amgen Inc. | Systems and approaches for sterilizing a drug delivery device |
EP3707075A1 (en) | 2017-11-06 | 2020-09-16 | Amgen Inc. | Fill-finish assemblies and related methods |
WO2019089178A1 (en) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Drug delivery device with placement and flow sensing |
MA50557A (fr) | 2017-11-10 | 2020-09-16 | Amgen Inc | Pistons pour dispositifs d'administration de médicament |
WO2019099324A1 (en) | 2017-11-16 | 2019-05-23 | Amgen Inc. | Door latch mechanism for drug delivery device |
MX2020005066A (es) | 2017-11-16 | 2020-08-20 | Amgen Inc | Autoinyector con deteccion de detencion y punto final. |
CN108219019B (zh) * | 2018-02-08 | 2020-03-20 | 华中科技大学 | 一种巯基化羟乙基淀粉及其修饰的纳米材料和制备方法 |
CN108503718B (zh) * | 2018-02-08 | 2020-03-20 | 华中科技大学 | 一种羟烷基淀粉偶联物及其制备方法和应用 |
CN108403641B (zh) * | 2018-02-08 | 2020-03-20 | 华中科技大学 | 一种载药纳米材料及其制备方法 |
US11191806B2 (en) * | 2018-05-04 | 2021-12-07 | Boris Farber | Polymyxin-based pharmaceutical composition for treating infectious diseases |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
US20210228815A1 (en) | 2018-07-24 | 2021-07-29 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
WO2020023451A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
MX2021000748A (es) | 2018-07-24 | 2021-03-26 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
WO2020023220A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation |
EP3829692A1 (en) | 2018-07-31 | 2021-06-09 | Amgen Inc. | Fluid path assembly for a drug delivery device |
CA3106452A1 (en) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Interventional dosing systems and methods |
WO2020068476A1 (en) | 2018-09-28 | 2020-04-02 | Amgen Inc. | Muscle wire escapement activation assembly for a drug delivery device |
CA3110529A1 (en) | 2018-10-02 | 2020-04-09 | Amgen Inc. | Injection systems for drug delivery with internal force transmission |
JP2022503989A (ja) | 2018-10-05 | 2022-01-12 | アムジエン・インコーポレーテツド | 投薬量インジケータを有する薬物送達デバイス |
KR20210076935A (ko) | 2018-10-15 | 2021-06-24 | 암젠 인크 | 댐핑 메커니즘을 갖는 약물 전달 장치 |
CA3109988A1 (en) | 2018-10-15 | 2020-04-23 | Amgen Inc. | Platform assembly process for drug delivery device |
US20220031939A1 (en) | 2018-11-01 | 2022-02-03 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
US11213620B2 (en) | 2018-11-01 | 2022-01-04 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
CN111157736A (zh) * | 2018-11-08 | 2020-05-15 | 中国科学院大连化学物理研究所 | 一种基于化学酶促的人血清o糖基化鉴定方法 |
MX2021012557A (es) | 2019-04-24 | 2021-11-12 | Amgen Inc | Conjuntos y metodos de verificacion de esterilizacion de jeringuillas. |
MX2022002149A (es) | 2019-08-23 | 2022-03-17 | Amgen Inc | Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados. |
IL307418A (en) | 2021-05-21 | 2023-12-01 | Amgen Inc | A method for optimizing a filling recipe for a drug container |
WO2024094457A1 (en) | 2022-11-02 | 2024-05-10 | F. Hoffmann-La Roche Ag | Method for producing glycoprotein compositions |
Family Cites Families (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE279486C (es) | ||||
US3191291A (en) * | 1959-01-21 | 1965-06-29 | Continental Can Co | Art of producing very thin steel and like sheets in wide strips |
CH397115A (de) * | 1960-10-04 | 1965-08-15 | Hoechst Ag | Verfahren zur Herstellung wasserunlöslicher Farbstoffe |
GB1385403A (en) | 1971-07-14 | 1975-02-26 | Unilever Ltd | Process for preparing oxidised carbohydrates |
GB1419080A (en) | 1972-12-29 | 1975-12-24 | Cheminova As | Chemical compounds having juvenile hormone activity |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4125492A (en) | 1974-05-31 | 1978-11-14 | Pedro Cuatrecasas | Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers |
US4001200A (en) | 1975-02-27 | 1977-01-04 | Alza Corporation | Novel polymerized, cross-linked, stromal-free hemoglobin |
US4001401A (en) | 1975-02-02 | 1977-01-04 | Alza Corporation | Blood substitute and blood plasma expander comprising polyhemoglobin |
US4061736A (en) * | 1975-02-02 | 1977-12-06 | Alza Corporation | Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin |
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
CA1055932A (en) | 1975-10-22 | 1979-06-05 | Hematech Inc. | Blood substitute based on hemoglobin |
DE2616086C2 (de) * | 1976-04-13 | 1986-04-03 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Substanz zur Verwendung in einem kolloidalen Blutvolumenersatzmittel aus Hydroxyethylstärke und Hämoglobin |
GB1578348A (en) * | 1976-08-17 | 1980-11-05 | Pharmacia Ab | Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic |
FR2378094A2 (fr) | 1977-01-24 | 1978-08-18 | Inst Nat Sante Rech Med | Nouveaux reactifs biologiques constitues par des supports solides sur lesquels sont couples des composes organiques comportant un residu glucidique |
EP0019403B1 (en) * | 1979-05-10 | 1985-07-31 | American Hospital Supply Corporation | Hydroxyalkyl-starch drug carrier |
DE3029307A1 (de) * | 1980-08-01 | 1982-03-04 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Haemoglobin enthaltendes blutersatzmittel |
US4454161A (en) * | 1981-02-07 | 1984-06-12 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Process for the production of branching enzyme, and a method for improving the qualities of food products therewith |
JPS57206622A (en) * | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
IE56026B1 (en) | 1982-10-19 | 1991-03-27 | Cetus Corp | Cysteine-depleted muteins of biologically active proteins |
ATE78293T1 (de) | 1983-05-27 | 1992-08-15 | Texas A & M Univ Sys | Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors. |
NO169637C (no) | 1983-10-11 | 1992-07-22 | Fidia Spa | Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner |
US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
US4496689A (en) * | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4952496A (en) * | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
IL77081A (en) | 1984-12-04 | 1999-10-28 | Genetics Inst | AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin |
DE3501616A1 (de) | 1985-01-17 | 1986-07-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur herstellung von hydroxylamin-derivaten |
US4667016A (en) | 1985-06-20 | 1987-05-19 | Kirin-Amgen, Inc. | Erythropoietin purification |
US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US5217998A (en) | 1985-07-02 | 1993-06-08 | Biomedical Frontiers, Inc. | Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid |
US4863964A (en) | 1985-07-02 | 1989-09-05 | Biomedical Frontiers, Inc. | Method for the stabilization of deferoxamine to chelate free ions in physiological fluid |
GB8610551D0 (en) | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
IT1203814B (it) | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | Esteri dell'acido alginico |
FR2600894B1 (fr) * | 1986-07-02 | 1989-01-13 | Centre Nat Rech Scient | Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications |
US5214132A (en) | 1986-12-23 | 1993-05-25 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
US5362853A (en) | 1986-12-23 | 1994-11-08 | Kyowa Hakko Kogyo Co., Ltd. | Polypeptide derivatives of human granulocyte colony stimulating factor |
JP2594123B2 (ja) * | 1987-09-12 | 1997-03-26 | 株式会社林原生物化学研究所 | 減感作剤 |
EP0307827A3 (en) | 1987-09-15 | 1989-12-27 | Kuraray Co., Ltd. | Novel macromolecular complexes, process for producing same and medicinal use of such complexes |
IL84252A (en) | 1987-10-23 | 1994-02-27 | Yissum Res Dev Co | Phospholipase inhibiting compositions |
US4904584A (en) | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
DK110188D0 (da) | 1988-03-02 | 1988-03-02 | Claus Selch Larsen | High molecular weight prodrug derivatives of antiinflammatory drugs |
FR2630329B1 (fr) | 1988-04-20 | 1991-07-05 | Merieux Inst | Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications |
IT1219942B (it) | 1988-05-13 | 1990-05-24 | Fidia Farmaceutici | Esteri polisaccaridici |
US4900780A (en) * | 1988-05-25 | 1990-02-13 | Masonic Medical Research Laboratory | Acellular resuscitative fluid |
US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US5420105A (en) * | 1988-09-23 | 1995-05-30 | Gustavson; Linda M. | Polymeric carriers for non-covalent drug conjugation |
US5218092A (en) | 1988-09-29 | 1993-06-08 | Kyowa Hakko Kogyo Co., Ltd. | Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains |
DE3836600A1 (de) * | 1988-10-27 | 1990-05-03 | Wolff Walsrode Ag | Kohlensaeureester von polysacchariden und verfahren zu ihrer herstellung |
ATE135370T1 (de) * | 1988-12-22 | 1996-03-15 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
US6261800B1 (en) | 1989-05-05 | 2001-07-17 | Genentech, Inc. | Luteinizing hormone/choriogonadotropin (LH/CG) receptor |
DE19975071I2 (de) | 1989-06-16 | 2000-02-03 | Fresenius Ag | Hydroxyethylstaerke als Plasmaexpander Verfahren zu ihrer Herstellung und Verwendung als kolloidales Plasmaersatzmittel |
JP2896580B2 (ja) * | 1989-08-25 | 1999-05-31 | チッソ株式会社 | アミロース―リゾチームハイブリッドと活性化糖およびその製造法 |
JP2838800B2 (ja) * | 1989-09-02 | 1998-12-16 | 株式会社林原生物化学研究所 | 減感作剤 |
KR100221066B1 (ko) | 1989-10-13 | 1999-10-01 | 스튜어트 엘.왓트 | 에리트로포이에틴 유사체와 그를 포함하는 제약학적 조성물 |
JP2975632B2 (ja) | 1990-03-30 | 1999-11-10 | 生化学工業株式会社 | グリコサミノグリカン修飾プロテイン |
US5169784A (en) | 1990-09-17 | 1992-12-08 | The Texas A & M University System | Baculovirus dual promoter expression vector |
DK130991D0 (da) * | 1991-07-04 | 1991-07-04 | Immunodex K S | Polymere konjugater |
US5281698A (en) * | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
DE4130807A1 (de) | 1991-09-17 | 1993-03-18 | Wolff Walsrode Ag | Verfahren zur herstellung von polysaccharidcarbonaten |
US6172208B1 (en) * | 1992-07-06 | 2001-01-09 | Genzyme Corporation | Oligonucleotides modified with conjugate groups |
AU5098193A (en) * | 1992-09-01 | 1994-03-29 | Berlex Laboratories, Inc. | Glycolation of glycosylated macromolecules |
GB2270920B (en) * | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
NZ250375A (en) | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
CA2110543A1 (en) | 1992-12-09 | 1994-06-10 | David E. Wright | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
FI935485A (fi) * | 1992-12-09 | 1994-06-10 | Ortho Pharma Corp | PEG-hydratsoni- ja PEG-oksiimisidoksen muodostavat reagenssit ja niiden proteiinijohdannaiset |
EP0601417A3 (de) * | 1992-12-11 | 1998-07-01 | Hoechst Aktiengesellschaft | Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung |
US5581476A (en) * | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
EP0646130B1 (en) | 1993-03-16 | 1996-12-11 | Hemosol Inc. | Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
AU7097094A (en) * | 1993-06-01 | 1994-12-20 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
IL192290A0 (en) | 1993-08-17 | 2008-12-29 | Kirin Amgen Inc | Erythropoietin analogs |
US5840900A (en) * | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
JPH07188291A (ja) | 1993-12-27 | 1995-07-25 | Hayashibara Biochem Lab Inc | 蛋白質とその製造方法並びに用途 |
US5876980A (en) * | 1995-04-11 | 1999-03-02 | Cytel Corporation | Enzymatic synthesis of oligosaccharides |
US6214331B1 (en) * | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
WO1996040662A2 (en) * | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
US5736533A (en) * | 1995-06-07 | 1998-04-07 | Neose Technologies, Inc. | Bacterial inhibition with an oligosaccharide compound |
US5981507A (en) * | 1995-12-14 | 1999-11-09 | Advanced Magnetics, Inc. | Polymeric carriers linked to nucleotide analogues via a phosphoramide bond |
US5723589A (en) | 1995-12-21 | 1998-03-03 | Icn Pharmaceuticals | Carbohydrate conjugated bio-active compounds |
EP1683520B1 (en) * | 1996-03-12 | 2013-11-20 | PG-TXL Company, L.P. | Water-soluble prodrugs |
US5696152A (en) | 1996-05-07 | 1997-12-09 | Wisconsin Alumni Research Foundation | Taxol composition for use as organ preservation and cardioplegic agents |
TW517067B (en) * | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
DE19628705A1 (de) * | 1996-07-08 | 1998-01-15 | Fresenius Ag | Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe |
US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US5851984A (en) * | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
US6011008A (en) * | 1997-01-08 | 2000-01-04 | Yissum Research Developement Company Of The Hebrew University Of Jerusalem | Conjugates of biologically active substances |
US5952347A (en) | 1997-03-13 | 1999-09-14 | Merck & Co., Inc. | Quinoline leukotriene antagonists |
US6299881B1 (en) * | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
AU750916C (en) * | 1997-08-07 | 2003-05-22 | University Of Utah, The | Prodrugs and conjugates of thiol- and selenol- containing compounds and methods of use thereof |
US5847110A (en) * | 1997-08-15 | 1998-12-08 | Biomedical Frontiers, Inc. | Method of reducing a schiff base |
US6875594B2 (en) | 1997-11-13 | 2005-04-05 | The Rockefeller University | Methods of ligating expressed proteins |
US6624142B2 (en) | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
DE19808079A1 (de) | 1998-02-20 | 1999-08-26 | Schering Ag | Hydroxyethylstärke-Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
WO1999045163A1 (fr) | 1998-03-05 | 1999-09-10 | Asahi Glass Company Ltd. | Cible de pulverisation cathodique, film conducteur transparent et son procede de production |
CA2233725A1 (en) | 1998-03-31 | 1999-09-30 | Hemosol Inc. | Hemoglobin-hydroxyethyl starch complexes |
US6153655A (en) * | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US6261594B1 (en) * | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
EP1035137A1 (en) * | 1999-03-12 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Method for the reductive amination of polysaccharides |
CZ299516B6 (cs) * | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem |
US7279176B1 (en) | 1999-09-02 | 2007-10-09 | Rice University | Nitric oxide-producing hydrogel materials |
US20020065410A1 (en) * | 1999-12-02 | 2002-05-30 | Antrim Richard L. | Branched starches and branched starch hydrolyzates |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6749865B2 (en) * | 2000-02-15 | 2004-06-15 | Genzyme Corporation | Modification of biopolymers for improved drug delivery |
US6586398B1 (en) * | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
JP2001294601A (ja) | 2000-04-11 | 2001-10-23 | Akita Prefecture | 高度分岐澱粉と該高度分岐澱粉の製造方法 |
JP2002003398A (ja) | 2000-04-17 | 2002-01-09 | Ltt Institute Co Ltd | 徐放製剤、その製造法及びワクチン |
DE10023051B4 (de) * | 2000-05-11 | 2004-02-19 | Roche Diagnostics Gmbh | Verfahren zur Herstellung von Fluoresceinisothiocyanat-Sinistrin, dessen Verwendung und Fluoresceinisothiocyanat-Sinistrin enthaltende diagnostische Zubereitung |
FR2811967B1 (fr) | 2000-07-24 | 2002-12-13 | Cebal | Tube muni d'une tete de fixation pour divers bouchages et les divers bouchages munis de moyens de fixation sur ledit tube |
DE10041541A1 (de) | 2000-08-24 | 2002-03-14 | Michael Duchene | Rekombinante Allergene aus der Motte Plodia interpunctella |
US6417347B1 (en) * | 2000-08-24 | 2002-07-09 | Scimed Life Systems, Inc. | High yield S-nitrosylation process |
EP1315511A4 (en) | 2000-09-08 | 2005-10-19 | Gryphon Therapeutics Inc | SYNTHESIS PROTEINS STIMULATING ERYTHROPOYSIS |
DE10105921A1 (de) | 2001-02-09 | 2002-08-14 | Braun Melsungen Ag | An Kolloide gebundene Arzneiwirkstoffe |
DE10112825A1 (de) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
DE10126158A1 (de) | 2001-05-30 | 2002-12-12 | Novira Chem Gmbh | Eine Methode zur Synthese von Gemischen einfach aktivierter und nicht aktivierter Polyoxyalkylene zur Modifizierung von Proteinen |
DE10129369C1 (de) | 2001-06-21 | 2003-03-06 | Fresenius Kabi De Gmbh | Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats |
DE10135694A1 (de) | 2001-07-21 | 2003-02-06 | Supramol Parenteral Colloids | Amphiphile Stärke-und Hydroxyethylstärke-Konjugate |
US7125843B2 (en) * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide |
US7179617B2 (en) * | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
ATE469164T1 (de) | 2001-10-26 | 2010-06-15 | Noxxon Pharma Ag | Modifizierte l-nukleinsäure |
US6375846B1 (en) | 2001-11-01 | 2002-04-23 | Harry Wellington Jarrett | Cyanogen bromide-activation of hydroxyls on silica for high pressure affinity chromatography |
DE10155098A1 (de) | 2001-11-09 | 2003-05-22 | Supramol Parenteral Colloids | Mittel zur Prävention von mykotischen Kontaminationen bei der Zell- und Gewebekultur bakteriellen, pflanzlichen, animalischen und humanen Ursprungs, bestehend aus Polyen-Makrolid-Konjugaten mit Polysacchariden |
US6916962B2 (en) | 2001-12-11 | 2005-07-12 | Sun Bio, Inc. | Monofunctional polyethylene glycol aldehydes |
DE10207072A1 (de) * | 2002-02-20 | 2003-08-28 | Supramol Parenteral Colloids | Stärkederivate, ihre Konjugate und Verfahren zur Herstellung derselben |
DE10209821A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
DE10209822A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
US8003089B2 (en) | 2002-03-13 | 2011-08-23 | Beijing Jiankai Technology Co., Ltd. | Y shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates |
DE10217994A1 (de) | 2002-04-23 | 2003-11-06 | Supramol Parenteral Colloids | Konjugate von hyperverzweigten Polysacchariden |
WO2003102018A2 (en) * | 2002-06-03 | 2003-12-11 | The Institute For Systems Biology | Methods for quantitative proteome analysis of glycoproteins |
US20040101546A1 (en) | 2002-11-26 | 2004-05-27 | Gorman Anne Jessica | Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents |
EP1591467A1 (en) | 2002-09-09 | 2005-11-02 | Nektar Therapeutics Al, Corporation | Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone |
RS20050202A (en) | 2002-09-09 | 2007-08-03 | Nektar Therapeuticals Al.Corporation, | Water-soluble polymer alkanals |
DE10242076A1 (de) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | HAS-Allergen-Konjugate |
KR101045401B1 (ko) * | 2002-09-11 | 2011-06-30 | 프레제니우스 카비 도이치란트 게엠베하 | 하이드록시알킬 전분 유도체 |
EP1400533A1 (en) | 2002-09-11 | 2004-03-24 | Fresenius Kabi Deutschland GmbH | HASylated polypeptides, especially HASylated erythropoietin |
EP1549350B1 (en) * | 2002-10-08 | 2008-09-24 | Fresenius Kabi Deutschland GmbH | Pharmaceutically active oligosaccharide conjugates |
DE10254745A1 (de) | 2002-11-23 | 2004-06-03 | Supramol Parenteral Colloids Gmbh | Imidazolide von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe |
DE10256558A1 (de) | 2002-12-04 | 2004-09-16 | Supramol Parenteral Colloids Gmbh | Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe |
SG145746A1 (en) | 2003-08-08 | 2008-09-29 | Fresenius Kabi De Gmbh | Conjugates of hydroxyalkyl starch and g-csf |
WO2005014655A2 (en) * | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
AU2004262921B2 (en) | 2003-08-08 | 2010-05-13 | Octapharma Ag | Conjugates of hydroxyalkyl starch and G-CSF |
BRPI0412671A (pt) * | 2003-08-08 | 2006-10-03 | Fresenius Kabi De Gmbh | conjugados de um polìmero e uma proteìna ligados por um grupo de ligação de oxima |
WO2005072778A2 (en) | 2004-01-29 | 2005-08-11 | Biosynexus, Inc. | Use of amino-oxy functional groups in the preparation of vaccines conjugates |
DE102004009783A1 (de) | 2004-02-28 | 2005-09-15 | Supramol Parenteral Colloids Gmbh | Hyperverzweigte Stärkefraktion, Verfahren zu ihrer Herstellung und ihre Konjugate mit pharmazeutischen Wirkstoffen |
BRPI0508607A (pt) | 2004-03-11 | 2007-07-31 | Fresenius Kabi De Gmbh | conjugados de amido de hidroxialquila e uma proteìna, preparados pela aminação redutiva |
EP1732609B1 (en) * | 2004-03-11 | 2012-07-11 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and a protein |
TW200603818A (en) * | 2004-03-11 | 2006-02-01 | Fresenius Kabi De Gmbh | Conjugates of hydroxyethyl starch and erythropoietin |
US20050265958A1 (en) | 2004-05-14 | 2005-12-01 | West Jennifer L | Nitric oxide releasing compositions and associated methods |
AU2006222187A1 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch |
EP1762250A1 (en) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
CA2628055C (en) | 2005-10-31 | 2013-10-01 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services | Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
JP2009093397A (ja) | 2007-10-09 | 2009-04-30 | Panasonic Corp | タッチパネル及びこれを用いた入力装置 |
EP2070950A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
EP2070951A1 (en) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Method for producing a hydroxyalkyl starch derivatives with two linkers |
US9434610B2 (en) | 2008-10-07 | 2016-09-06 | Rexahn Pharmaceuticals, Inc. | HPMA—docetaxel conjugates and uses therefore |
-
2003
- 2003-08-08 KR KR1020057004002A patent/KR101045401B1/ko not_active IP Right Cessation
- 2003-08-08 CA CA2496317A patent/CA2496317C/en not_active Expired - Fee Related
- 2003-08-08 WO PCT/EP2003/008829 patent/WO2004024776A1/en active Application Filing
- 2003-08-08 AU AU2003253399A patent/AU2003253399B2/en not_active Ceased
- 2003-08-08 BR BR0314107-1A patent/BR0314107A/pt not_active Application Discontinuation
- 2003-08-08 BR BR0314106-3A patent/BR0314106A/pt not_active IP Right Cessation
- 2003-08-08 MX MXPA05002591A patent/MXPA05002591A/es active IP Right Grant
- 2003-08-08 RU RU2005110415/04A patent/RU2329274C2/ru not_active IP Right Cessation
- 2003-08-08 KR KR1020057003928A patent/KR101174510B1/ko not_active IP Right Cessation
- 2003-08-08 RU RU2005110412/04A patent/RU2326891C2/ru not_active IP Right Cessation
- 2003-08-08 IL IL16650603A patent/IL166506A0/xx unknown
- 2003-08-08 MX MXPA05002594A patent/MXPA05002594A/es active IP Right Grant
- 2003-08-08 JP JP2004535075A patent/JP2006516534A/ja not_active Withdrawn
- 2003-08-08 CA CA002495242A patent/CA2495242A1/en not_active Abandoned
- 2003-08-08 KR KR1020057003902A patent/KR101045422B1/ko not_active IP Right Cessation
- 2003-08-08 WO PCT/EP2003/008858 patent/WO2004024761A1/en active Application Filing
- 2003-08-08 WO PCT/EP2003/008859 patent/WO2004024777A1/en active Application Filing
- 2003-08-08 CN CNA038214644A patent/CN1681844A/zh active Pending
- 2003-08-08 PL PL03375037A patent/PL375037A1/xx unknown
- 2003-08-08 AU AU2003260393A patent/AU2003260393B2/en not_active Ceased
- 2003-08-08 MX MXPA05002593A patent/MXPA05002593A/es active IP Right Grant
- 2003-08-08 BR BR0314227-2A patent/BR0314227A/pt not_active Application Discontinuation
- 2003-08-08 CN CNB038214652A patent/CN100348618C/zh not_active Expired - Fee Related
- 2003-08-08 PL PL374490A patent/PL217085B1/pl unknown
- 2003-08-08 PL PL374969A patent/PL216545B1/pl not_active IP Right Cessation
- 2003-08-08 RU RU2005110423/04A patent/RU2328505C2/ru not_active IP Right Cessation
- 2003-08-08 AU AU2003255406A patent/AU2003255406B2/en not_active Ceased
- 2003-08-29 AR ARP030103141A patent/AR041097A1/es active IP Right Grant
- 2003-09-10 TW TW092124954A patent/TW200418875A/zh unknown
- 2003-09-11 AT AT03020424T patent/ATE406387T1/de active
- 2003-09-11 DE DE60323192T patent/DE60323192D1/de not_active Expired - Lifetime
- 2003-09-11 DE DE0001398328T patent/DE03020425T1/de active Pending
- 2003-09-11 AT AT03020425T patent/ATE449112T1/de active
- 2003-09-11 ES ES03020425T patent/ES2213507T3/es not_active Expired - Lifetime
- 2003-09-11 SI SI200331733T patent/SI1398328T1/sl unknown
- 2003-09-11 DK DK03020424T patent/DK1398327T3/da active
- 2003-09-11 DE DE20321836U patent/DE20321836U1/de not_active Expired - Lifetime
- 2003-09-11 ES ES09012453T patent/ES2399006T3/es not_active Expired - Lifetime
- 2003-09-11 DE DE0001398327T patent/DE03020424T1/de active Pending
- 2003-09-11 EP EP09012453A patent/EP2143736B1/en not_active Expired - Lifetime
- 2003-09-11 SI SI200331431T patent/SI1398327T1/sl unknown
- 2003-09-11 ES ES03020424T patent/ES2213506T3/es not_active Expired - Lifetime
- 2003-09-11 EP EP03020425A patent/EP1398328B1/en not_active Expired - Lifetime
- 2003-09-11 PT PT03020423T patent/PT1398322E/pt unknown
- 2003-09-11 EP EP03020423A patent/EP1398322B1/en not_active Expired - Lifetime
- 2003-09-11 PT PT03020424T patent/PT1398327E/pt unknown
- 2003-09-11 EP EP10011835A patent/EP2316850A3/en not_active Withdrawn
- 2003-09-11 DK DK03020423T patent/DK1398322T3/da active
- 2003-09-11 EP EP09014352A patent/EP2154160A1/en not_active Withdrawn
- 2003-09-11 EP EP08012908A patent/EP2017287A3/en not_active Withdrawn
- 2003-09-11 AT AT03020423T patent/ATE323723T1/de active
- 2003-09-11 PT PT03020425T patent/PT1398328E/pt unknown
- 2003-09-11 ES ES03020423T patent/ES2213505T3/es not_active Expired - Lifetime
- 2003-09-11 DK DK03020425.9T patent/DK1398328T3/da active
- 2003-09-11 DE DE0001398322T patent/DE03020423T1/de active Pending
- 2003-09-11 EP EP10011836.3A patent/EP2272865A3/en not_active Withdrawn
- 2003-09-11 DE DE60330098T patent/DE60330098D1/de not_active Expired - Lifetime
- 2003-09-11 DE DE60304640T patent/DE60304640T2/de not_active Expired - Lifetime
- 2003-09-11 EP EP03020424A patent/EP1398327B1/en not_active Expired - Lifetime
-
2004
- 2004-08-06 ZA ZA200600651A patent/ZA200600651B/xx unknown
- 2004-08-09 AR ARP040102851A patent/AR045235A1/es active IP Right Grant
- 2004-08-09 AR ARP040102850A patent/AR045234A1/es active IP Right Grant
- 2004-08-18 HK HK04106173A patent/HK1063477A1/xx not_active IP Right Cessation
- 2004-08-18 HK HK04106171A patent/HK1063475A1/xx not_active IP Right Cessation
- 2004-08-18 HK HK04106174.1A patent/HK1063478A1/xx not_active IP Right Cessation
- 2004-08-18 HK HK10103783.3A patent/HK1136226A1/xx not_active IP Right Cessation
-
2005
- 2005-01-26 IL IL166506A patent/IL166506A/en not_active IP Right Cessation
- 2005-02-16 IL IL166931A patent/IL166931A/en not_active IP Right Cessation
- 2005-02-16 IL IL166930A patent/IL166930A/en not_active IP Right Cessation
- 2005-03-11 US US11/078,582 patent/US8618266B2/en not_active Expired - Fee Related
- 2005-03-11 US US11/077,906 patent/US7815893B2/en not_active Expired - Fee Related
- 2005-03-11 US US11/078,098 patent/US20050238723A1/en not_active Abandoned
- 2005-03-17 NO NO20051427A patent/NO20051427L/no not_active Application Discontinuation
- 2005-03-17 NO NO20051419A patent/NO20051419L/no active IP Right Review Request
-
2009
- 2009-07-30 IL IL200150A patent/IL200150A0/en unknown
- 2009-11-20 AU AU2009238372A patent/AU2009238372B2/en not_active Ceased
-
2010
- 2010-02-16 CY CY20101100153T patent/CY1109813T1/el unknown
- 2010-06-04 MX MX2010006175A patent/MX2010006175A/es active IP Right Grant
- 2010-06-28 US US12/824,618 patent/US20120046240A9/en not_active Abandoned
- 2010-07-06 JP JP2010153807A patent/JP5455821B2/ja not_active Expired - Fee Related
- 2010-07-06 JP JP2010153808A patent/JP5275293B2/ja not_active Expired - Fee Related
- 2010-08-12 US US12/855,381 patent/US8475765B2/en not_active Expired - Fee Related
- 2010-11-30 JP JP2010266646A patent/JP2011089125A/ja active Pending
-
2011
- 2011-01-14 AU AU2011200158A patent/AU2011200158B2/en not_active Ceased
- 2011-01-14 AU AU2011200219A patent/AU2011200219B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR045234A1 (es) | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. | |
TW200806328A (en) | One-part hair dye composition | |
EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
MX2009012183A (es) | Moleculas depuradoras del oxigeno, articulos que contienen las mismas y sus metodos de uso. | |
CR9421A (es) | Compuestos heterociclicos fusionados | |
BRPI0505310A (pt) | processo para a preparação de soluções aquosas fluxìveis, altamente concentradas, de betaìnas | |
BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
BR9910297A (pt) | Novos análogos graxos para o tratamento de diabetes | |
PE20020476A1 (es) | Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos | |
WO2007025889A3 (en) | Dyes containing a thiol group | |
CO5650218A2 (es) | Composiciones de enjuague bucal que contienen sales del alquil ester de n-acil arginina | |
SV2006002126A (es) | Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica | |
MX2009004343A (es) | Compuestos organicos. | |
ATE485261T1 (de) | Salicylsäurederivate | |
CY1115623T1 (el) | Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ | |
HK1111168A1 (en) | A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS | |
AR053559A1 (es) | Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados | |
BR0211826A (pt) | Imidazopiridinas tricìclicas | |
BRPI0607230A2 (pt) | inibidores de protease hiv | |
AR057555A1 (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo | |
TR200201783T2 (tr) | 5-Siyanofatalid hazırlamak için yöntem | |
BRPI0411308A (pt) | composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto | |
AR028740A1 (es) | Procedimiento para la preparacion de pirazolopirimidinonas | |
AR029767A1 (es) | Procedimiento para la preparacion de compuestos de pirazolo (4, 3-d) pirimidin-7-onas-3-piridilsulfonilo y compuestos intermediarios utiles en dicho procedimiento. | |
UY28857A1 (es) | 17a (alfa)-fluoroesteroides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FG | Grant, registration |